Healthcare & Pharmaceuticals Industry Press Releases

Published on May 8, 2025 - 21:00 GMT

Nova Leap Health Corp. Posts Q1 2025 Results

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 08, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 21:00 GMT

VitalHub Reports First Quarter 2025 Results

Annual Recurring Revenue (ARR)⁽¹⁾ up 54% YoY to $73.7 million Total Revenue up 42% YoY to $21.7 million Adjusted EBITDA⁽¹⁾ up 39% YoY to $5.6 million TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 09:00 GMT

3 California Dispensaries Redefine Standards in Cannabis Retail

Space Flyt, Wonderbrett, and Cannabis House Lead a New Era of Design, Community Engagement, and Customer-Centric Cannabis Retail Across California LOS ANGELES, CA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- California remains at the …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on May 8, 2025 - 21:00 GMT

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 21:00 GMT

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 8, 2025 - 08:31 GMT

17th Gulf Heart Association Conference

17th Gulf Heart Association Conference, November 20-22, Doha, Qatar DOHA, QATAR, May 8, 2025 /⁨EINPresswire.com⁩/ -- The Gulf Heart Association (GHA) is excited to announce the upcoming 17th GHA Conference, set to be held in Doha, Qatar from …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on May 8, 2025 - 20:30 GMT

Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD ...

Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS CITY, Kan., May 08, 2025 (GLOBE NEWSWIRE) -- Cingulate …

Distribution channels:

Published on May 8, 2025 - 20:30 GMT

BioSyent Schedules First Quarter Earnings Release for May 15, 2025

MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 20:30 GMT

Galecto Reports First Quarter 2025 Operating and Financial Results

BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …

Distribution channels:

Published on May 8, 2025 - 20:30 GMT

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025

MELVILLE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …

Distribution channels:

Published on May 8, 2025 - 08:29 GMT

Now Open: Iowa Behavioral Associates Accepting Patients Statewide

Now open in West Des Moines, Iowa Behavioral Associates is accepting new patients and offering expert care for anxiety, depression, PTSD, and more. WEST DES MOINES, IA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Iowa Behavioral Associates …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 08:27 GMT

17th Gulf Heart Association Conference

DOHA, QATAR, May 8, 2025 /⁨EINPresswire.com⁩/ -- مايو 20258 مؤتمر جمعية القلب الخليجية السابع عشر الدوحة، قطر – يسرّ جمعية القلب الخليجية (GHA) أن تعلن عن انطلاق مؤتمرها في نسخته السابعة عشرة. ومن المزمع انعقاد المؤتمر في الدوحة، قطر، خلال …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on May 8, 2025 - 20:17 GMT

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 20:15 GMT

Precision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025

GARDNER, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 20:15 GMT

AMN Healthcare Announces First Quarter 2025 Results

Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45 DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations …

Distribution channels:

Published on May 8, 2025 - 20:15 GMT

Globus Medical Reports First Quarter 2025 Results

AUDUBON, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2025. Worldwide net sales were $598.1 million, a decrease …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 8, 2025 - 20:15 GMT

CooperCompanies to Participate in the William Blair Growth Stock Conference

SAN RAMON, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the William Blair Growth Stock Conference on Thursday, June 5, 2025. Brian Andrews, Executive …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 20:14 GMT

Progyny, Inc. Announces First Quarter 2025 Results

Reports Record Revenue of $324.0 Million, Reflecting 16.5% Growth Raises Full Year Guidance Due to Strong Start to the Year Early Selling Season Activity Reflects Ongoing Demand in Women's Health and Family Building Solutions NEW YORK, May 08, 2025 ( …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 20:05 GMT

Oculis Reports Q1 2025 Financial Results and Provides Company Update

The recent R&D Day (replay) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high unmet medical need, thanks to Privosegtor’s (OCS-05) …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 20:05 GMT

Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates

– Ongoing clinical studies for four candidates on track with data expected in 2025, including interim Phase 1b data for long-acting helicase-primase inhibitors ABI-5366 and ABI-1179 anticipated in fall 2025 – – New data from multiple programs highlighted …

Distribution channels:

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire